This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the potential of Patisiran in patients with ATTR Amyloidosis with Cardiomyopathy based on the recent data presented from the APOLLO-B Phase 3 Study

Ticker(s): ALNY

Who's the expert?

Institution: UPMC Heart and Vascular Institute

  • Cardiologist and Critical Care Physician, board certified in Cardiovascular Medicine, Critical Care Medicine, Echocardiography, and Nuclear Cardiology.
  • treats ~500 patients with hypertension per year
  • Clinical interests include structural echocardiography, critical care cardiology, and critical care echocardiography

Interview Goal
see title.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.